Alto Neuroscience, Inc. ("Alto") , a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced a favorable ...

Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX100 to 800 Patients SHIELD II Enrolled more than ...

Introduction Blood and blood products are essential for patients in need of transfusion therapy, especially those undergoing ...

Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...

Kim Newcomer, director of volunteers, Colorectal Cancer Alliance, discusses a study conducted with Takeda and the Harris Poll ...

Background Cancer, a major global health challenge, not only threatens lives but also imposes severe financial burdens, known ...

Onbe, a market-leading corporate disbursements platform, published its Winter 2025 Patient Refund Survey, revealing that timely, digital patient refun ...

Across healthcare system, stakeholders share blame for high costs. This includes hospitals, drugmakers, insurers and others ...

The same strain is linked to the bird flu patient who died in Louisiana ... and limit further disease spread," the agency said in a statement on its website. Herd of cows eating hay in a dairy ...

The constituents of the International Ankle Consortium and other similar organisations have yet to properly define the clinical phenomenon known as CAI and its related characteristics for consistent ...

| With budget reconciliation right around the corner, different slices of the healthcare industry have made their views clear on issues like physician pay, ACA subsidies, telehealth flexibilities, ...